A Game-Changer for Poorly Soluble APIs

A Game-Changer for Poorly Soluble APIs

Fact: Over 70% of active pharmaceutical ingredients (APIs) entering the drug development pipeline are poorly water-soluble and thus, insufficiently bioavailable.

Nanomilling is one of the most effective proven techniques used to resolve solubility challenges and can be applied to almost any API with water solubility below 200 μg/mL. Benefits include particle size reduction, ease of scalability, reduced fed/fasted variability in both liquid and solid dosage forms, faster onset of therapeutic action, and low excipient side effects.

Learn more about our extensive expertise in nanomilling with a broad range of APIs, or speak with one of our formulation experts to find out how we can help.
 
Related resources that may interest you:

•    Webpage: Global CDMO for Drug Manufacturing and Analytical Testing Services
•    Scientific Journal: Nanomilling for Better Solubility and Enhanced Bioavailbility
•    Webinar: The Development of Nanosuspension Formulations